- Barron’s cover story this weekend says that commodities may not be as exciting as cryptocurrencies or tech stocks, but they could be the right investment at the right time.
- Other featured articles discuss how the first three IPOs of 2022 disappointed and why Wall Street is starting to worry about Visa.
- Also, the positive outlook for a major telecom company and how investors are horrified by a large drug stock after a new Alzheimer’s treatment.
“Why It’s Time to Invest in Commodities, and How to Do It” by Reshma Kapadia, examines how commodities are at the crossroads of three of today’s biggest investment themes – rising inflation, a changing China, and the transition away from fossil fuels amid increased interest in climate change.
Find out why the first IPOs of 2022, including three biotech companies Amylyx Pharmaceuticals Inc (NASDAQ: AMLX), and Vigil Neuroscience Inc (NASDAQ:VIGL), “The first three initial public offerings of the year are struggling. Here’s why,” unfortunate results are announced by Luisa Beltran.
Daren Fonda writes in his book “Visa Is Thundered by Crypto and Digital Wallets. What to Watch”, Daren Fonda Visa company (NYSE: V) The startup of payments, digital wallets, and cryptocurrencies is upset — and Wall Street is starting to worry.
shares AT&T Inc. (NYSE:T) was rising Friday after receiving an upgrade from Wells Fargo on limited downside risks, Sabrina Escobar writes about the expectations of an analyst at AT&T’s Bear Case in large numbers.
“Biogen’s Alzheimer’s Drug Has Another Chance for Success” by Josh Nathan Kazis. Biogen Corporation (NASDAQ:BIIB) An Alzheimer’s treatment, Aduhelm, has been a disappointment to the company since its Food and Drug Administration approval last spring, and investors are dismayed.
See also: Benzinga Bulls and Bears last week: Tesla, Viacom, CBS, Tilray, Salesforce and more
Also on Barron’s this week:
Electric vehicles, TVs, virtual reality, and more: Big trends at this year’s CES
4.5 million Americans have left their jobs. Should you?
What we can learn from our failures in the coronavirus crisis
Robinhood changes happen. Watch their stock.
The breakout in the bond market hits the stock. Why won’t he block the march?
At the time of writing, the author has no position in the said stocks.
Keep up with the latest breaking news and trading ideas by following Benzinga on Twitter.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.